The anti-colorectal cancer monoclonal antibody CO17-1A (mAb CO), which recognizes the tumor-associated antigen EpCAM, was expressed in transgenic Arabidopsis plants. PCR and western blot analyses showed the insertion and expression of heavy chain (HC)/HC fused to the KDEL ER retention modif (HCK) and light chain (LC) of mAb CO and mAb CO with HCK (mAb COK) in Arabidopsis transformants. Both plantderived mAb P CO and mAb P COK were purified from a biomass of approximately 1,000 seedlings grown in a greenhouse. In sandwich ELISA, both mAb P CO showed a slightly higher binding affinity for the target, EpCAM, compared to mAb M CO. In cell ELISA, both mAbs P COs showed binding affinity to the human colorectal cancer cell line SW480. Furthermore, mAb M CO, mAb P CO, and mAb P COK exhibited dose and timedependent regression effects on SW480 cells in vitro. In summation, both mAb P CO and mAb P COK, expressed in Arabidopsis, recognized the target antigen EpCAM and showed anti-proliferative activity against human colorectal cancer cells. [BMB Reports 2020; 53(4): 229-233]